National Health Investors (NHI)
(Delayed Data from NYSE)
$83.01 USD
-1.05 (-1.25%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $83.08 +0.07 (0.08%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$83.01 USD
-1.05 (-1.25%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $83.08 +0.07 (0.08%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Zacks News
Are You Looking for a Top Momentum Pick? Why National Health Investors (NHI) is a Great Choice
by Zacks Equity Research
Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.
ESRT vs. NHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
ESRT vs. NHI: Which Stock Is the Better Value Option?
Is Global X SuperDividend U.S. ETF (DIV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DIV
Is it a Wise Decision to Hold Healthpeak Properties Stock Now?
by Zacks Equity Research
DOC is well-poised to gain from high demand for lab assets and rising senior citizens' healthcare spending despite competitive and high interest rate environment.
ESRT vs. NHI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ESRT vs. NHI: Which Stock Is the Better Value Option?
National Health Investors (NHI) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.
National Health Investors (NHI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for National Health Investors (NHI) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
National Health Investors (NHI) Q2 FFO and Revenues Beat Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of 7.27% and 4.26%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Stag Industrial (STAG) Q2 FFO and Revenues Beat Estimates
by Zacks Equity Research
Stag (STAG) delivered FFO and revenue surprises of 3.39% and 1.47%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
National Health Investors (NHI) Is Up 3.44% in One Week: What You Should Know
by Zacks Equity Research
Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is It Wise to Hold Healthpeak Properties (DOC) Stock Now?
by Zacks Equity Research
High demand for lab assets and rising senior citizens' healthcare spending benefit Healthpeak Properties (DOC). However, competition from peers and higher interest rates are concerns.
Is Global X SuperDividend U.S. ETF (DIV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DIV
Are You Looking for a Top Momentum Pick? Why National Health Investors (NHI) is a Great Choice
by Zacks Equity Research
Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.
National Health Investors (NHI) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for National Health Investors (NHI) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Strength Seen in Innovative Industrial Properties (IIPR): Can Its 4.8% Jump Turn into More Strength?
by Zacks Equity Research
Innovative Industrial Properties (IIPR) witnessed a jump in share price last session on above-average trading volume. The latest trend in FFO estimate revisions for the stock doesn't suggest further strength down the road.
Industrial Logistics Properties Trust (ILPT) Tops Q1 FFO and Revenue Estimates
by Zacks Equity Research
Industrial Logistics Properties Trust (ILPT) delivered FFO and revenue surprises of 7.69% and 1.54%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
National Health Investors (NHI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for National Health Investors (NHI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
National Health Investors (NHI) Q4 FFO Top Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of 0.93% and 0.32%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Four Corners Property Trust (FCPT) Q4 FFO Surpass Estimates
by Zacks Equity Research
Four Corners Property (FCPT) delivered FFO and revenue surprises of 2.38% and 0.85%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
National Health Investors (NHI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for National Health Investors (NHI) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Extra Space Storage (EXR) Surges 3.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Extra Space Storage (EXR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in FFO estimate revisions may not translate into further price increase in the near term.
Whitestone (WSR) Soars 7.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Whitestone (WSR) witnessed a jump in share price last session on above-average trading volume. The latest trend in FFO estimate revisions for the stock doesn't suggest further strength down the road.
Compared to Estimates, National Health Investors (NHI) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for National Health Investors (NHI) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
National Health Investors (NHI) Q2 FFO and Revenues Miss Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of -2.75% and 16.79%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Clipper Realty Inc. (CLPR) Misses Q2 FFO and Revenue Estimates
by Zacks Equity Research
Clipper Realty Inc. (CLPR) delivered FFO and revenue surprises of -7.14% and 0.70%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?